Allergan to buy MAP Pharma for about $958 mln

January 22
8:54 PM 2013

U.S. specialty drugmaker Allergan Inc said late on Tuesday it will buy MAP Pharmaceuticals Inc for about $958 million in cash.

As per the deal, Allergan will acquire 100 percent of the shares of MAP Pharmaceuticals for a price of $25 per share, a 60 percent premium over MAP's closing stock price on the Nasdaq of $15.58 on Tuesday. 

© 2023 VCPOST, All rights reserved. Do not reproduce without permission.


Join the Conversation

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics